Načítá se...
Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment
AIM: 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) is valuable in the management of patients with oesophageal cancer, but a role in gastric cancer staging is debated. Our aim was to review the role of FDG PET-CT in a large gastric cancer cohort in a tertiary UK...
Uloženo v:
| Vydáno v: | Eur J Nucl Med Mol Imaging |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7075833/ https://ncbi.nlm.nih.gov/pubmed/31377821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-019-04429-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|